...
首页> 外文期刊>Journal of the Chinese Chemical Society >Reactions of 6-acetyl-4-methyl-5-(1-pyrrolyl)-2-phenylthieno-[2,3-d]pyrimidine in heterocyclic synthesis: Convenient route to some Schiff's bases, chalcones, pyridines, pyridin-2(1H)-ones and 2H-pyran-2-one derivatives incorporating a 5-(I-pyrrolyl)-
【24h】

Reactions of 6-acetyl-4-methyl-5-(1-pyrrolyl)-2-phenylthieno-[2,3-d]pyrimidine in heterocyclic synthesis: Convenient route to some Schiff's bases, chalcones, pyridines, pyridin-2(1H)-ones and 2H-pyran-2-one derivatives incorporating a 5-(I-pyrrolyl)-

机译:6-乙酰基-4-甲基-5-(1-吡咯基)-2-苯基噻吩并[[2,3-d]嘧啶在杂环合成中的反应:通往某些席夫碱,查耳酮,吡啶,吡啶2(1H)的便捷途径)和2H-吡喃-2-酮衍生物并入5-(I-吡咯基)-

获取原文
获取原文并翻译 | 示例
           

摘要

Treatment of 6-acetyl-5-amino-4-methyl-2-phenylthieno[2,3-d]pyrimidine 3 with 2,5-dimethoxytetrahydrofuran afforded the 6-acetyl-5-(1-pyrrolyl)-4-methyl-2-phenylthieno[2,3-d]pyrimidine 4, which can react with appropriate primary amines 5a-f to yield the corresponding Schiff's base derivatives 6a-f. The reaction of acetyl compound 4 with appropriate arylaldehydes 14a-k and arylmethylidenemalononitriles 18a-afforded the corresponding 6-(3-substituted-acryloyl)-5-(1-pyrrolyl)-4-methyl-2-phenylthieno[2,3-d]pyrimidines 15a-k and 6-[3-cyano-2-ethoxy-4-(4-substituted-phenyl)-pyridin-6-yl]-5-(I-pyrrolyl)-4-methyl-2phenyl-thieno[2,3-d]pyrimidines 21a-f under basic conditions, respectively. On the other hand, the 6-(3cyano-1,2-dihydro-4-substituted-2-oxopyridin-6-yl)-5-(1-pyrrolyl)-4-methyl-2-phenylthieno[2,3-d]pyrimidines 26a,b and 6-(3-substituted-amido-4-substituted-pyran-2-on-6-yl)-5-(I-pyrrolyl)-4-methyl-2-phenylthieno[2,3-d]pyrimidines 30a-c were obtained by intramolecular cyclization of 6-(3-dimethylamino-3s ubstituted-acryloyl)-5-(1-pyrrolyl)-4-methyl -2-phenylthieno [2,3-d]pyrimidines 23a,b with cyanoacetamide 24 and N-acylglycines 27a,b, respectively.
机译:用2,5-二甲氧基四氢呋喃处理6-乙酰基-5-氨基-4-甲基-2-苯基噻吩并[2,3-d]嘧啶3,得到6-乙酰基-5-(1-吡咯基)-4-甲基-可以与合适的伯胺5a-f反应的2-苯基噻吩并[2,3-d]嘧啶4,产生相应的席夫碱衍生物6a-f。乙酰基化合物4与适当的芳醛14a-k和芳基亚甲基丙二腈18a的反应使相应的6-(3-取代的丙烯酰基)-5-(1-吡咯基)-4-甲基-2-苯基噻吩并[2,3-d ]嘧啶15a-k和6- [3-氰基-2-乙氧基-4-(4-取代-苯基)-吡啶-6-基] -5-(1-吡咯基)-4-甲基-2-苯基-噻吩并[在碱性条件下的2,3-d]嘧啶21a-f。另一方面,6-(3-氰基-1,2-二氢-4-取代-2-氧吡啶并-6-基)-5-(1-吡咯基)-4-甲基-2-苯基噻吩并[2,3- d]嘧啶26a,b和6-(3-取代的氨基-4-取代的吡喃-2-基-6-基)-5-(1-吡咯基)-4-甲基-2-苯基噻吩并[2,3 -d]嘧啶30a-c是通过6-(3-二甲基氨基-3s取代的丙烯酰基)-5-(1-吡咯基)-4-甲基-2-苯基噻吩并[2,3-d]嘧啶23a的分子内环化获得的。分别用氰基乙酰胺24和N-酰基甘氨酸27a,b。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号